Cancers, Vol. 16, Pages 1891: Comparing the Outcomes of Matched and Mismatched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation with Different Anti-Thymocyte Globulin Formulations: A Retrospective, Double-Centre Experience on Behalf of the Polish Adult Leukemia Group
Cancers, Vol. 16, Pages 1891: Comparing the Outcomes of Matched and Mismatched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation with Different Anti-Thymocyte Globulin Formulations: A Retrospective, Double-Centre Experience on Behalf of the Polish Adult Leukemia Group
Cancers doi: 10.3390/cancers16101891
Authors:
Ugo Giordano
Monika Mordak-Domagała
Małgorzata Sobczyk-Kruszelnicka
Sebastian Giebel
Lidia Gil
Krzysztof D. Dudek
Jarosław Dybko
Despite notable advancements in immunotherapy in the past decades, allogeneic hematopoietic stem cell transplantation (allo-HCT) remains a promising, potentially curative treatment modality. Only a limited number of studies have performed a direct comparison of two prevalent rabbit anti-thymocyte globulin (r-ATG) formulations—specifically, Thymoglobuline (ATG-T, formerly Genzyme) and Grafalon (ATG-G, formerly Fresenius). The primary objective of our retrospective analysis was to compare the outcomes of adult patients undergoing matched or mismatched unrelated donor (MUD/MMUD) allo-HCT, with a graft-versus-host disease (GvHD) prophylaxis based on either ATG-T or ATG-G. A total of 87 patients who had undergone allo-HCT between 2012 and 2022 were included. We observed no significant differences between ATG-T and ATG-G concerning the occurrence of acute graft-versus-host disease (aGvHD), regardless of its severity. Conversely, chronic graft-versus-host disease (cGvHD) occurred less frequently in t...
Source: Cancers - Category: Cancer & Oncology Authors: Ugo Giordano Monika Mordak-Domaga ła Ma łgorzata Sobczyk-Kruszelnicka Sebastian Giebel Lidia Gil Krzysztof D. Dudek Jaros ław Dybko Tags: Article Source Type: research
More News: Acute Leukemia | Cancer | Cancer & Oncology | Chronic Leukemia | Cytomegalovirus | Immunotherapy | Leukemia | Poland Health | Stem Cell Therapy | Stem Cells | Study | Transplants